ghk cu 100 GHK-Cu Copper Peptide 100MG GHK-CU COPPER PEPTIDE 5MG/10MG/50MG/100MG VIAL
Description
A toxic dose has never been recorded
Observed adverse events such as myalgia and headaches were classified as mild to moderate and assessed as unrelated to the interventions.20 This means that researchers ultimately determined that the headaches and muscle pain experienced by patients during the studies were not due to urolithin A supplementation
This isn't just another compound
Limitations and Research Status While preclinical data is extensive, large-scale human clinical trials are limited
